Home NDC 83257-035 YESAFILI
Product NDC 83257-035
11-digit product format 832570035
Labeler code 83257
Product ID 83257-035_88493494-d5f4-a7bc-4fec-e32507aff7af
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name aflibercept-jbvf
Dosage form INJECTION, SOLUTION
Route INTRAVITREAL
Labeler Biocon Biologics Inc.
Application BLA761274
Marketing category BLA
Marketing start 2026-08-03
Substance AFLIBERCEPT
Active strength 2 mg/.05mL
Pharmacologic classes Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base YESAFILI
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AFLIBERCEPT 2 mg/.05mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 15C2VL427D Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2749097 Internal RxNorm lookup 2749104 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761274 Yesafili aflibercept-jbvf 351(k) Interchangeable Rx 2026-08-01
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Status 83257-035-41 83257003541 1 SYRINGE, GLASS in 1 CARTON (83257-035-41) / .05 mL in 1 SYRINGE, GLASS 2026-08-03 0 Current